Current Opinion in Allergy and Clinical Immunology was launched in 2001. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of allergy and clinical immunology are divided into 14 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Editors-in-Chief and Section Editors for this issue.
Dr Mark Ballow received his MD from the University of Chicago Pritzker School of Medicine, USA. After a pediatric residency at Yale-New Haven Hospital, he completed an immunology fellowship at the University of Minnesota Hospitals, USA. He was the chief of clinical and experimental immunology at Walter Reed Army Medical Center. He was then appointed as Chief of the division of clinical immunology in the Department of Pediatrics at the University of Connecticut, USA from 1975 to 1988, and became Chief of the division of allergy/clinical immunology and pediatric rheumatology, and Program Director of the allergy/immunology fellowship program at The Women and Children's Hospital of Buffalo, State University of New York at Buffalo, USA in 1988.
Dr Ballow is certified by the American Board of Pediatrics, American Board of Allergy & Immunology (ABAI), and in Clinical Laboratory Immunology. He was on the Board of Directors of the ABAI from 1992 – 1998. He has served on four editorial boards including the Journal of Allergy and Clinical Immunology (1984 – 1989; 1995 – 2000), and is an Ad Hoc reviewer for a number of pediatric, allergy and immunology journals.
Dr Ballow has served as an ad hoc member of several NIH study sections, and was a member of the committee that published the first Allergy and Immunology Medical Knowledge Self Assessment Program (MK-SAP), and was a member of the new 3rd edition AI-MK-SAP. Dr Ballow is a Fellow of the American Academy of Asthma, Allergy and Immunology, and has served on the Board of Directors of the Academy (1996 – 1999), and has chaired the A/I Training Program Directors, Basic Clinical immunology Interest Section, and the Post-graduate Education Program. He was President of the American Academy of Asthma, Allergy and Immunology in 2010–2011.
Dr Ballow is a member of the Clinical Immunology Society, the Buffalo Allergy Society, the Society for Pediatric Research, and the American Pediatric Society. He also has served on the Blood Product Advisory Committee of the FDA. Dr Ballow's major clinical interests include inner city asthma, chronic sinusitis, clinical immunology, and the uses and mechanisms of action of Intravenous Immune Globulin (IGIV). His research interests include the immunology of the newborn infant and the immunoregulatory effects of IVIG, Vitamin A and retinoic acid.
G. Walter Canonica
Professor Giorgio Walter Canonica is Chairman of the Dept of Medical Specialties (University Hospital S. Martino Genoa, Italy) and Director of the Allergy & Respiratory Diseases Clinic, Genoa University, Italy, a Galen Centre of Excellence. Professor Canonica first specialised in pulmonary diseases after having received his medical degree from the University of Genoa, Italy. He then specialised in Allergy and Clinical Immunology at Florence University, Italy. He subsequently conducted clinical immunology and allergology research in several European universities and institutes, in addition to two years at the Medical University of South Carolina, USA. Since returning to the University of Genoa in 1995, Professor Canonica has held a number of academic positions including Director of the Speciality School of Allergy and Clinical Immunology, Director of the Specialty School of Pulmonary Diseases and Chairman of the Allergy & Respiratory Diseases Clinic.
He is Board Member of ARIA (Allergic Rhinitis and its impact Asthma) guidelines.
Professor Canonica's research interests include examination of the molecular events and interactions between immunocompetent cells, inflammatory cells and epithelial cells in allergic inflammation and airway remodelling. He is particularly involved in new strategies in the treatment of allergic disease, including biological response modifiers, such as specific immunotherapy (with a special focus on SLIT – sublingual immunotherapy). Professor Canonica has published extensively in international journals and acts as a referee of many immunology journals. In addition, Professor Canonica is a member of a number of societies, and recently served 6 years as Secretary General and President Elect of the World Allergy Organisation (WAO), he was president of WAO 2008/09. He is also 1st Vice President of Interasma. He is President Elect of the SIAIC, Italian Society of Allergy & Clinical Immunology (2011–2014).
Prof. Ruby Pawankar works at the Division of Rhinology & Allergy, Department of Otolaryngology, Nippon Medical School, Tokyo, Japan, is a Guest Professor at Kyung Hee University School of Medicine, Seoul, Korea and has been Guest Professor at the Department of Pediatrics, Showa University School of Medicine, Tokyo. Having graduated in medicine from the Armed Forces Medical College in Pune, India, and specializing in ENT from BJ Medical College, India, she did her fellowship and training in Allergy & Immunology and her doctorate at the Nippon Medical School and Juntendo University School of Medicine in Tokyo, Japan.
She is a Member of the Board of Directors of the World Allergy Organization, an Executive Committee Member of the ARIA Initiative and Chair of its Asia-Pacific Affiliate. She is a council / committee member/ honorary fellow of several initiatives and national and international societies in allergy. She is a Founder President of the International Symposium on Allergy ISBAAR, Director of the Asian Allergy Asthma Foundation and has served as President of the 4th ISBAAR in Tokyo, the 10th Congress of the Trans Pacific Allergy & Immunology Society and the 9th Asian Rhinology Congress.
Dr Pawankar is a co-author of International Consensus documents, has more than 300 publications, and is an Associate Editor/ Editorial Board Member of many international journals like Current Opinion in Allergy & Clinical Immunology, Clinical Experimental Allergy, WAO Journal, International Archives Allergy & Immunology, and the American Journal of Rhinology. She is a member of several prestigious academic organizations like the “Collegium International Allergolicum” and is a recipient of several prestigious national and international academic awards and orations worldwide including the International Distinguished Fellow Award of the American College of Allergy Asthma and Immunology (ACAAI).
David P. Skoner
Dr David P. Skoner is Director of Allergy, Asthma, and Immunology in the Department of Pediatrics of Allegheny General Hospital in Pittsburgh, Pennsylvania, USA. He is also Professor of Pediatrics at the Drexel University College of Medicine in Philadelphia, Pennsylvania, USA and Clinical Professor of Pediatrics, West Virginia University School of Medicine, USA. Previously, he was Associate Professor of Pediatrics and Otolaryngology at the University of Pittsburgh, School of Medicine in Pittsburgh, Pennsylvania, USA, and has served as the Chief of the Section of Allergy/Immunology and Director of the Allergy and Immunology Training Program at the Children's Hospital of Pittsburgh.
Dr Skoner received his BS degree from Juniata College in Huntingdon, Pennsylvania, USA, and his MD degree from Temple University in Philadelphia, Pennsylvania, USA. He served his residency in general pediatrics at Children's Hospital in Cincinnati, Ohio and he completed his fellowship in allergy/immunology at Children's Hospital in Pittsburgh.
His current research interests include the relationships between respiratory viruses, asthma, immunity, and stress; the relationship between viral and allergen-induced nasal inflammation and middle ear disease; and the efficacy and safety (HPA axis function and growth in children) of inhaled and intranasal steroids. Dr Skoner has received NIH funding and written more than 100 articles and given more than 200 presentations on respiratory disease. His articles and abstracts have been published in many leading journals, including Pediatrics, Journal of Allergy and Clinical Immunology, Pediatric Research, American Journal of Respiratory and Critical Care Medicine, JAMA, and American Review of Respiratory Disease. Dr Skoner serves on the editorial advisory boards of the journals Current Allergy and Asthma Reports, and Current Opinion in Allergy and Clinical Immunology, and previously served on the editorial board of the American Journal of Rhinology. He is a Fellow of the American Academy of Pediatrics and a member of the Society of Pediatric Research, the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma & Immunology, the Association for Research in Otolaryngology, and the American Pediatric Society. He has been recognized as one of America's “Top Doctors” (Pediatric Allergy & Immunology, Castle Connolly Medical Ltd.) from 2001 to 2011, as one of the Most Influential Doctors by USA TODAY (http://www.usatoday.com/yourlife/health/most-influential-doctors.htm), and as a U.S. News Top Doctor (www.usnews.com/top-doctors). He was recently invited to join the Best Pharmaceuticals for Children Act (BPCA) Pediatric Asthma Therapeutics Group convened by the National Institute of Child Health and Human Development.
Dr Skoner co-founded the Nemacolin Asthma Conference, a CME programs that attracts a national and an international audience and faculty, now in its sixth year. He also founded and is the President of For Your Good Health, a Pennsylvania non-profit corporation that brings together asthma stakeholders in the development and implementation of state-of the-art programs to educate children with asthma and their caregivers about the disease and its management. The aim of these programs is to reduce asthma's impact on patients, caregivers, the community, and the healthcare system by helping the patients to lead near-normal lives.
Stephen T. Holgate
Stephen T. Holgate is Medical Research Council Clinical Professor of Immunopharmacology at the School of Medicine, Southampton, UK. Over 30 years, he has utilized many approaches to study asthma and allied disorders including epidemiology, pathology and immunology, pharmacology, experimental medicine and genetics. Over the last decade his work has focused more on the role of the epithelium in orchestrating the chronic inflammatory and remodeling responses in relation to environmental insults. His work has resulted in over 900 peer reviewed publications and 430 book chapters and reviews. He has edited 45 books including texts on Allergy, Air Pollution and Asthma. His work has been rewarded with several prizes including the Graham Bull Prize of the Royal College of Physicians for Clinical Research and the King Faisal International Prize for Medicine. He has been President of the British Society of Allergy and Clinical Immunology and in 2007 President of the British Thoracic Society. He advises the UK Government and EU on issues relating to Air Pollution and Chemical Hazards, has been a member of the Royal Commission on Environmental Pollution. He is Chair of the Research Excellence Framework (REF) Main Panel A: Medicine, Health and Life Sciences. He has also just been appointed to Commander of the Order of the British Empire (CBE).
J. Andrew Grant
Dr Grant is a native of Florida and received his undergraduate degree from Harvard University, USA in biochemical sciences. After attending Duke Medical School, USA, he did a residency in internal medicine at New York Hospital – Cornell Medical Center in New York City, USA. He did a fellowship in immunology with Leroy Hood at the National Institutes of Health and an allergy-immunology clinical fellowship at Johns Hopkins University, USA with Phillip Norman and Lawrence Lichtenstein. In 1973, he established the first basic and clinical research program in allergy in Texas at the University of Texas Medical Branch in Galveston, USA. Presently he is Professor in the Departments of Medicine and Microbiology-Immunology and training program director in Allergy-Immunology at that institution. He has served as division Director and Vice Chair for Research within the Department of Internal Medicine.
Dr Grant has been an active member of the American Academy of Allergy, Asthma and Immunology for over three decades. His contributions to this organization include chairing the Training Program Directors’ Committee, Mechanisms of Allergy Interest Section, Postgraduate Education Committee, Scientific Workshops and Exhibits Committee, and Immunotherapy Committee. He served on the Editorial Board of the Journal of Allergy and Clinical Immunology. Currently he chairs the In-training Examination Committee.
Dr Grant served as president of the Texas Allergy Asthma and Immunology Society and a director of the American Board of Allergy and Immunology. He chaired the Pulmonary Allergy Drugs Advisory Committee of the Food and Drugs Administration. Currently he is on the Residency Review Committee for Allergy and Immunology.
Dr Grant's research interests have included mechanisms of cellular activation especially the role of chemokines and novel therapies for allergic disorders. He was a visiting professor at the National Heart and Lung Institute with Professor Barry Kay in 1994. He has authored over 180 publications and chapters and 150 presentations at national and international meetings.